{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:00:57Z","timestamp":1792692057881,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ygyno.2017.11.010","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T04:01:55Z","timestamp":1510286515000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the National Cancer Database"],"prefix":"10.1016","volume":"148","author":[{"given":"Karina","family":"Nieto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-3808","authenticated-orcid":false,"given":"William","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nghia","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec M.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Harkenrider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.11.010_bb0005","unstructured":"Key statistics for endometrial cancer? http:\/\/www.cancer.org\/cancer\/endometrialcancer\/detailedguide\/endometrial-uterine-cancer-key-statistics. Updated 2016. Accessed 11\/17, 2016."},{"issue":"1","key":"10.1016\/j.ygyno.2017.11.010_bb0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2007.04.032","article-title":"The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a gynecologic oncology group study","volume":"106","author":"McMeekin","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0090-8258(90)90279-T","article-title":"Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases","volume":"40","author":"Abeler","year":"1991","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.11.010_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00004347-199501000-00006","article-title":"Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival","volume":"14","author":"Carcangiu","year":"1995","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00125480-200405000-00001","article-title":"Non-endometrioid carcinomas of the uterine corpus: a review of their pathology with emphasis on recent advances and problematic aspects","volume":"11","author":"Clement","year":"2004","journal-title":"Adv. Anat. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.11.010_bb0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a society of gynecologic oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.11.010_bb0035","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/IGC.0b013e3182150c89","article-title":"Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study","volume":"21","author":"Greggi","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2017.11.010_bb0040","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2017.11.010_bb0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/gyno.1995.1210","article-title":"Endometrial carcinoma in elderly women","volume":"58","author":"Hoffman","year":"1995","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.11.010_bb0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/j.1600-0412.2000.079004311.x","article-title":"Prognostic significance of serous and clear cell adenocarcinoma in surgically staged endometrial carcinoma","volume":"79","author":"Sakuragi","year":"2000","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2017.11.010_bb0055","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2017.11.010_bb0060","article-title":"Prognostic factors in endometrial clear cell carcinoma","author":"Cetinkaya","year":"2016","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2017.11.010_bb0065","unstructured":"National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology. Uterine neoplasms version 1.2017. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf. Updated 2016. Accessed 03\/23, 2017."},{"issue":"2","key":"10.1016\/j.ygyno.2017.11.010_bb0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ygyno.2009.02.003","article-title":"Management of women with clear cell endometrial cancer: a society of gynecologic oncology (SGO) review","volume":"113","author":"Olawaiye","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2017.11.010_bb0075","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1200\/JCO.2002.08.171","article-title":"Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a gynecologic oncology group study","volume":"20","author":"Muggia","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0080","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/annonc\/mdg112","article-title":"Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC gynaecological cancer group","volume":"14","author":"van Wijk","year":"2003","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.11.010_bb0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0090-8258(89)90605-7","article-title":"Trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a gynecologic oncology group study","volume":"33","author":"Thigpen","year":"1989","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.11.010_bb0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1996.0227","article-title":"A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a gynecologic oncology group study","volume":"62","author":"Ball","year":"1996","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2017.11.010_bb0095","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0360-3016(02)04404-8","article-title":"Outcome and patterns of failure in pathologic stages I\u2013IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy","volume":"55","author":"Murphy","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.ygyno.2017.11.010_bb0100","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0002-9378(94)70340-X","article-title":"Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma","volume":"170","author":"Smith","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.11.010_bb0105","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2007.11.008","article-title":"Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review","volume":"108","author":"Thomas","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.11.010_bb0110","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","article-title":"Randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy (VCB\/C) in patients with high risk (HR), early stage endometrial cancer (EC): a gynecologic oncology group trial","volume":"134","author":"McMeekin","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.11.010_bb0115","series-title":"2017 ASTRO Annual Meeting Accepted Late Breaking Abstracts, LB1","article-title":"A phase 3 trial of pelvic radiation therapy versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy in patients with high-risk, early-stage endometrial cancer: a gynecology oncology group study","author":"Randall","year":"2017"},{"issue":"4","key":"10.1016\/j.ygyno.2017.11.010_bb0120","doi-asserted-by":"crossref","first-page":"e639","DOI":"10.1016\/j.ijrobp.2011.01.053","article-title":"Impact of adjuvant external-beam radiation therapy in early-stage uterine papillary serous and clear cell carcinoma","volume":"81","author":"Kim","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.ygyno.2017.11.010_bb0125","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1525-1438.2007.01082.x","article-title":"Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?","volume":"18","author":"Kwon","year":"2008","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2017.11.010_bb0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/cncr.21592","article-title":"Use of the national cancer data base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) special population committee","volume":"106","author":"Newman","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/biomet\/80.3.557","article-title":"Checking the cox model with cumulative sums of martingale-based residuals","volume":"80","author":"Lin","year":"1993","journal-title":"Biometrika"},{"issue":"4","key":"10.1016\/j.ygyno.2017.11.010_bb0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control. Clin. Trials"},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0145","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0090-8258(92)90130-B","article-title":"Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma","volume":"47","author":"Carcangiu","year":"1992","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0090-8258(90)90250-O","article-title":"Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases","volume":"39","author":"Abeler","year":"1990","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2017.11.010_bb0155","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/1097-0142(19950501)75:9<2239::AID-CNCR2820750908>3.0.CO;2-7","article-title":"Uterine papillary serous carcinoma. A clinical study","volume":"75","author":"Gitsch","year":"1995","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0160","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/gyno.1999.5505","article-title":"Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma","volume":"74","author":"Cirisano","year":"1999","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.11.010_bb0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1006\/gyno.2000.5737","article-title":"The outcome of stage I\u2013II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma","volume":"77","author":"Cirisano","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0170","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0090-8258(90)90268-P","article-title":"Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium","volume":"39","author":"Lanciano","year":"1990","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2017.11.010_bb0175","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/COC.0000000000000065","article-title":"Adjuvant pelvic radiation therapy+\/\u2212vaginal brachytherapy in patients with high-risk stage I or stage II uterine papillary serous, clear cell, and high-grade endometrioid carcinoma","volume":"39","author":"Nagar","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0180","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-8258(03)00199-9","article-title":"Improved outcome at 10years for serous-papillary\/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation","volume":"90","author":"Martinez","year":"2003","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2017.11.010_bb0185","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2017.11.010_bb0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ygyno.2005.08.037","article-title":"Adjuvant whole abdominal irradiation in clinical stages I and II papillary serous or clear cell carcinoma of the endometrium: a phase II study of the gynecologic oncology group","volume":"100","author":"Sutton","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.11.010_bb0195","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2012.12.026","article-title":"Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer","volume":"129","author":"Townamchai","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2017.11.010_bb0200","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijrobp.2012.03.011","article-title":"The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer","volume":"85","author":"Barney","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817315068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817315068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T17:46:38Z","timestamp":1560361598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817315068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0090825817315068"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.11.010","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the National Cancer Database","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}